Przejdź do zawartości

Leczenie urazów i medycyna ratunkowa

Optymalizacja i utrzymanie hemostazy

Środki antyfibrynolityczne

Alternatives to allogeneic platelet transfusion. (opens new window)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Źródło‎: Br J Haematol 2016;175(3):381-92.

Indeks‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (opens new window)

Antifibrinolytic drugs for acute traumatic injury. (opens new window)

Ker K, Roberts I, Shakur H, Coats TJ.

Źródło‎: Cochrane Database Syst Rev 2015;(5):CD004896.

Indeks‎: PubMed 25956410

DOI‎: 10.1002/14651858.CD004896.pub4

https://www.ncbi.nlm.nih.gov/pubmed/25956410 (opens new window)

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (opens new window)

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE.

Źródło‎: JAMA Surg 2013;148(3):218-25.

Indeks‎: PubMed 23670117

DOI‎: 10.1001/jamasurg.2013.764

https://www.ncbi.nlm.nih.gov/pubmed/23670117 (opens new window)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (opens new window)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Źródło‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Indeks‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (opens new window)

Topical tranexamic acid compared with anterior nasal packing for treatment of epistaxis in patients taking antiplatelet drugs: randomized controlled trial. (opens new window)

Zahed R, Mousavi Jazayeri MH, Naderi A, Naderpour Z, Saeedi M

Źródło‎: Acad Emerg Med 2018;25(3):261-6.

Indeks‎: PubMed 29125679

DOI‎: 10.1111/acem.13345

https://www.ncbi.nlm.nih.gov/pubmed/29125679 (opens new window)

Rekombinowany aktywowany czynnik VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (opens new window)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Źródło‎: Transfusion 2009;49 Suppl 5:240S-7S.

Indeks‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (opens new window)

Koncentraty czynników krzepnięcia

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (opens new window)

Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M.

Źródło‎: Injury 2013;44(2):209-16.

Indeks‎: PubMed 23000050

DOI‎: 10.1016/j.injury.2012.08.047

https://www.ncbi.nlm.nih.gov/pubmed/23000050 (opens new window)

Desmopresyna

Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (opens new window)

Furay EJ, Daley MJ, Satarasinghe P, Lara S, Aydelotte JD, Teixeira PG, Coopwood TB, Ali S, Brown CVR

Źródło‎: J Trauma Acute Care Surg 2020;88(1):80-6.

Indeks‎: PubMed 31688782

DOI‎: 10.1097/TA.0000000000002521

https://www.ncbi.nlm.nih.gov/pubmed/31688782 (opens new window)

Badania różnicujące krwawienie chirurgiczne z krwawieniem z koagulopatii (TEG)

Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (opens new window)

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT.

Źródło‎: Acta Anaesthesiol Scand 2010;54(1):111-7.

Indeks‎: PubMed 19860752

DOI‎: 10.1111/j.1399-6576.2009.02132.x

https://www.ncbi.nlm.nih.gov/pubmed/19860752 (opens new window)